Ana de Barros, PhD, managing science editor —

People living in regions with deprived, disadvantaged conditions have higher probabilities of suffering cognitive dysfunctions than those living in regions with more developed living conditions, according to a study from the University of Ulster in United Kingdom, led by Professor Helene McNulty. The results of the research based on Ireland data revealed…

The Alzheimer’s Association recently awarded Jose Abisambra, assistant professor at the University of Kentucky and researcher at the Sanders-Brown Center on Aging, a $100,000 New Investigator Research Grant to fund his work into understanding the function of a brain protein that alters during the development of Alzheimer’s disease. The…

New diagnostics are currently being developed by researchers to help doctors ascertain risk factors for Alzheimer’s Disease before the onset of symptoms. A recent study showed that a brain scan lasting no longer than 5 minutes could potentially yield results indicative of dementia risk by determining…

The Massachusetts Institute of Technology (MIT) AgeLab recently joined forces with the Transamerica companies to discuss significant financial issues regarding patients suffering from Alzheimer’s and their families, as well as to initiate a framework for new guidelines in effectively serving clients facing the disease. The meeting recently took place at the “Financial…

A novel, personalized treatment program with the ability to reverse the cognitive impairment caused by Alzheimer’s disease may have been discovered by a researcher from the Buck Institute Research on Aging, in Novato, California and the University of California-Los Angeles. The findings of the study, which focused on combined therapies…

Scientists from Yale School of Medicine are calling on willing participants for one of two clinical trials for pharmaceutical treatments against Alzheimer’s disease, which until this day, scientists have yet to find a cure for. The only drugs available on the market today are…

A group of researchers have recently discovered Alzheimer’s patients’ unusual ability to retain emotion despite memory loss. According to the findings of their study, which is now available in the September 2014 issue of Cognitive and Behavioral Neurology, patients with Alzheimer’s disease may not remember…

A Boston-based private biotech company has revealed it has begun the first-in-human clinical trial for one of their leading pipeline products for Alzheimer’s disease — the most common form of dementia that affects over 5 million Americans today, and is the cause of more than 500,000 deaths among older…

Patients who claim to suffer memory loss may in fact be experiencing the first symptoms of Alzheimer’s disease and may come to suffer from clinical memory impairment years later, according to a recent research conducted at the University of Kentucky’s Sanders-Brown Center on Aging. The study confirmed the importance…

There is still a series of misunderstandings and ignorance regarding Alzheimer’s disease, according to a survey conducted by the Alzheimer’s Association, which showed that 59 percent of the people surveyed wrongly believe that the disease is a normal part of aging, and 40 percent of them don’t think Alzheimer’s is deadly. The survey,…